<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18126" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Balloon Valvuloplasty</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bykowski</surname>
            <given-names>Adam</given-names>
          </name>
          <aff>Mclaren Health System</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Perez</surname>
            <given-names>Oscar A.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kanmanthareddy</surname>
            <given-names>Arun</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Adam Bykowski declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Oscar Perez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Arun Kanmanthareddy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18126.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Balloon valvuloplasty is a cardiac intervention to open up a stenotic or stiffed heart valves (e.g., aortic or mitral) using a catheter with a balloon on the tip. It is also known as balloon valvotomy. It is a less invasive procedure because it is done by inserting a catheter into the blood vessel from groin percutaneously rather than valve replacement with cardiothoracic surgical or other open methods. This activity reviews the indications of balloon valvuloplasty and highlights the role of the interprofessional team in the management of these patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications for balloon valvuloplasty.</p></list-item><list-item><p>Describe the technique of balloon valvuloplasty.</p></list-item><list-item><p>Recall the potential complications of balloon valvuloplasty.</p></list-item><list-item><p>Discuss interprofessional team strategies for improving care coordination and communication to advance the technique of balloon valvuloplasty and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18126&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18126">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18126.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Balloon valvuloplasty&#x000a0;is a cardiac intervention to open up a stenotic or stiffed heart valves (e.g., aortic or mitral) using a catheter with a balloon on the tip. It is also known as balloon valvotomy. It is a less invasive procedure because it is done by inserting a catheter into the blood vessel from groin percutaneously rather than valve replacement with cardiothoracic surgical or other open methods. Balloon valvulotomy has several types, depending upon which heart valve is involved for example:</p>
        <list list-type="bullet">
          <list-item>
            <p>Percutaneous balloon tricuspid valvuloplasty</p>
          </list-item>
          <list-item>
            <p>Percutaneous balloon pulmonary valvuloplasty</p>
          </list-item>
          <list-item>
            <p>Percutaneous balloon mitral valvuloplasty</p>
          </list-item>
          <list-item>
            <p>Percutaneous balloon aortic valvuloplasty<xref ref-type="bibr" rid="article-18126.r1">[1]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18126.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>The heart is a four-chamber blood-pumping organ in the chest cavity. Blood flows from one chamber to another through valves. The following are the four valve classifications:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tricuspid valve: present between the right atrium and ventricle</p>
          </list-item>
          <list-item>
            <p>Pulmonary valve: present between the&#x000a0;right ventricle and pulmonary article</p>
          </list-item>
          <list-item>
            <p>Mitral valve: a bicuspid valve present between the left atrium and ventricle</p>
          </list-item>
          <list-item>
            <p>Aortic valve: present between the left ventricle and ascending aorta</p>
          </list-item>
        </list>
        <p>With the ongoing age, any inflammation or infection of the valve or a congenital heart defect causes the leaflets of valves to become stiff and calcified hence causing hindrance in the flow of blood from one chamber to another.<xref ref-type="bibr" rid="article-18126.r2">[2]</xref></p>
      </sec>
      <sec id="article-18126.s4" sec-type="Indications">
        <title>Indications</title>
        <p>The balloon valvuloplasty can be used for treating stenosis of tricuspid, pulmonary, mitral, and aortic valves, but in some cases, its potential risks outweigh its potential benefits. The following are the indications of balloon valvuloplasty in different valvular stenosis.&#x000a0;</p>
        <p><bold>Tricuspid Valve Stenosis</bold>&#x000a0;</p>
        <p>The treatment of tricuspid stenosis is a combination of medical and valvular interventions. For patients with severe tricuspid valve stenosis, valve replacement surgery is preferred over balloon valvulotomy as most cases are associated&#x000a0;with tricuspid regurgitation, and balloon valvuloplasty can worsen regurgitation. To choose balloon valvuloplasty over tricuspid valve replacement surgery in an isolated, symptomatic, severe tricuspid stenosis with mild to less tricuspid regurgitation, the surgical risk of a patient must be too high and outweigh disadvantages of over benefits of balloon valvuloplasty.</p>
        <p>
<bold>Pulmonary Valve Stenosis</bold>
</p>
        <p>Percutaneous balloon pulmonary valvulotomy (BPV) is preferred in moderate (gradient 40 to 60 mmHg) to severe (greater than 60 mmHg) pulmonary stenosis and it is the first-line treatment of typical dome-shaped valvular pulmonary stenosis in severe stenosis (gradient greater than 60 mmHg). BPV is also the preferred treatment&#x000a0;in neonates with critical pulmonary stenosis.</p>
        <p>
<bold>Mitral Valve Stenosis</bold>
</p>
        <p>The percutaneous mitral balloon valvuloplasty is the treatment of choice in patients with mitral valve stenosis who have following features:</p>
        <list list-type="bullet">
          <list-item>
            <p>Severe mitral stenosis</p>
          </list-item>
          <list-item>
            <p>Pliable, noncalcified mitral valves</p>
          </list-item>
          <list-item>
            <p>Symptomatic</p>
          </list-item>
          <list-item>
            <p>The absence of left atrial thrombus</p>
          </list-item>
          <list-item>
            <p>The absence of moderate to severe mitral regurgitation</p>
          </list-item>
          <list-item>
            <p>Older patients or who are at high risk for surgery</p>
          </list-item>
        </list>
        <p>It is primarily performed in patients with rheumatic mitral stenosis. There is a little experience with percutaneous balloon mitral valvuloplasty in congenital mitral stenosis.</p>
        <p>
<bold>Aortic Valve Stenosis</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Use in calcified aortic stenosis</bold>: Use of balloon aortic valvotomy (BAV) is limited in calcified aortic stenosis. The use is generally limited to two&#x000a0;settings:</p>
          </list-item>
        </list>
        <p>
<list list-type="order"><list-item><p>Percutaneous BAV is used as a bridge to surgical aortic valve replacement or transcatheter aortic valve replacement (TAVR) in a severely symptomatic aortic stenosis</p></list-item><list-item><p>For patients with a severely symptomatic aortic stenosis who require an urgent non-cardiac surgery</p></list-item></list>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Use in congenital aortic stenosis</bold>: Balloon aortic valvotomy (or valvuloplasty, BAV) is a first-line treatment option for children and younger adults with aortic stenosis with the congenital disease without significant valve calcification.<xref ref-type="bibr" rid="article-18126.r3">[3]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18126.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>The percutaneous balloon valvuloplasty is contraindicated if in the presence&#x000a0;of moderate to severe valvular regurgitation, infective endocarditis, vegetation, tumor, or irreversible noncardiac disease that is severely limiting life.&#x000a0;<xref ref-type="bibr" rid="article-18126.r4">[4]</xref></p>
      </sec>
      <sec id="article-18126.s6" sec-type="Preparation">
        <title>Preparation</title>
        <p>Admit the patient to the hospital a day before the procedure for preparation. A detailed history should be taken especially for cardiac and pulmonary diseases.&#x000a0;Questions&#x000a0;regarding age, weight, height, previous medical history, and&#x000a0;medications including anticoagulants; heart, vascular, liver, kidney, and musculoskeletal disease and any current symptoms; any allergies in the past; complications&#x000a0;during previous surgeries or complications of anesthesia in any family member; and social and sexual history should be documented. The patient is not allowed to eat or drink after midnight and should remain nill per oral (NPO) until after the procedure.&#x000a0;<xref ref-type="bibr" rid="article-18126.r4">[4]</xref></p>
      </sec>
      <sec id="article-18126.s7" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>The procedure started with a local anesthetic injection at the site of catheter insertion. Some IV sedative medicines are also given to help the patient relax before the procedure. After identifying the site of insertion just above the vessel in the groin, the doctor inserts an introducer into the vessel which helps with the later&#x000a0;introduction of the catheter through the&#x000a0;vessel into the heart. Following catheterization, the practitioner begins injecting contrast dye from the IV line to check the exact place of catheter and valve. As he or she approaches the required position, the balloon&#x000a0;is inflated, forcing the calcified valve leaflets open. By fracturing the calcified deposits within the leaflets, the inflated balloon relieves the stenosis. After that, the practitioner deflates the balloon and removes the catheter.&#x000a0;<xref ref-type="bibr" rid="article-18126.r5">[5]</xref></p>
      </sec>
      <sec id="article-18126.s8" sec-type="Complications">
        <title>Complications</title>
        <p>A variety of complications are associated with balloon valvuloplasty. The following are some of the main complications:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bleeding or hematoma formation at the catheter site insertion</p>
          </list-item>
          <list-item>
            <p>Infection at the catheter site</p>
          </list-item>
          <list-item>
            <p>Vessel damage due to multiple puncturing attempts</p>
          </list-item>
          <list-item>
            <p>Contrast dye allergy</p>
          </list-item>
          <list-item>
            <p>Arrhythmia</p>
          </list-item>
          <list-item>
            <p>Stroke</p>
          </list-item>
          <list-item>
            <p>Valve rupture requiring open heart surgery</p>
          </list-item>
          <list-item>
            <p>Ventricular rupture&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Valve regurgitation<xref ref-type="bibr" rid="article-18126.r6">[6]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18126.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Balloon valvuloplasty is a less invasive&#x000a0;than open-heart valve replacement, but it is not an alternative to valve replacements.</p>
        <p>Studies comparing ballon tricuspid valvuloplasty to surgical tricuspid valve replacement are not available, so in most of the cases, tricuspid valve surgery is preferred. However, in high-risk surgical cases&#x000a0;or with moderate to severe valvular regurgitation associated with tricuspid stenosis, balloon tricuspid valvuloplasty can be performed.</p>
        <p>Pulmonary stenosis is a common congenital heart disease characterized by the right ventricular outflow obstruction. The clinical significance in treating pulmonary stenosis in children mainly depends on the severity of obstruction. Mild pulmonary stenosis (gradient &#x0003c;greater than 0 mmHg) does not require intervention. In moderate pulmonary stenosis (gradient 40 to 60 mmHg) and severe pulmonary stenosis (gradient greater than 60 mmHg), balloon pulmonary valvuloplasty is preferred.</p>
        <p>The outcome of clinical trials on the clinical significance of percutaneous balloon mitral valvuloplasty compared to open and closed surgical commissurotomy was that percutaneous mitral balloon valvuloplasty was good or better than surgery in patients who were candidates for valvotomy.</p>
        <p>Percutaneous balloon aortic valvuloplasty has a limited role in the treatment of calcific aortic stenosis. BAV is first-line therapy in children and younger adults with aortic stenosis due to congenital disease (generally due to bicuspid commissural fusion) without significant valve calcification.<xref ref-type="bibr" rid="article-18126.r3">[3]</xref></p>
      </sec>
      <sec id="article-18126.s10" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Balloon valvoplasty is a cardiac intervention technique that is widely used today to manage stenotic lesions. However, the preoperative work is usually done by an interprofessional team. The patients need to meet the indications for valvuloplasty to derive the most benefits. The nurse practitioner, physician assistant, anesthesiologist, and cardiologist should ensure patient fitness for the procedure. Usually, the nurse practitioner or&#x000a0;physician assistant does the initial screening and reports back to the clinical team leader if there are concerns. The cardiologist should ensure and confirm with the nurse practitioner or physician assistant that the patient has the right indications for valvuloplasty. A nurse in the cardiac catheterization lab is dedicated to the monitoring of the patient during the procedure and should report to the cardiologist if any abnormal changes in vital signs develop. After the procedure, the recovery room nurses need to monitor the patient's vital signs and the site of puncture for hematoma formation and distal leg pulses. If there is an elevation in heart rate or drop in blood pressure, the physician should be contacted immediately. Only through an interprofessional team approach can the morbidity of this procedure be decreased and the outcomes improved. [Level V]</p>
      </sec>
      <sec id="article-18126.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18126&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18126">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18126/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18126">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-18126.s12">
        <fig id="article-18126.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Graphic showing Balloon Valvuloplasty Graphic by Emma Gregory</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Balloon_Valvuloplastyxalternatex__aorticx-01" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-18126.s13">
        <title>References</title>
        <ref id="article-18126.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahfouz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Elawady</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Goda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moustafa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Redo Scoring for Prediction of Success of Redo-Percutaneous Balloon Mitral Valvuloplasty in Patients with Mitral Restenosis.</article-title>
            <source>J Heart Valve Dis</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>537</fpage>
            <page-range>537-546</page-range>
            <pub-id pub-id-type="pmid">29762922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18126.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pozzoli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zuber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reisman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maisano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Taramasso</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Comparative Anatomy of Mitral and Tricuspid Valve: What Can the Interventionlist Learn From the Surgeon.</article-title>
            <source>Front Cardiovasc Med</source>
            <year>2018</year>
            <volume>5</volume>
            <fpage>80</fpage>
            <pub-id pub-id-type="pmid">30009160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18126.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ford</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Brassil</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kushwaha</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Allan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pitney</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jepson</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Balloon Aortic Valvuloplasty in the Transcatheter Valve Era: Single Centre Indications and Early Safety Data in a High Risk Population.</article-title>
            <source>Heart Lung Circ</source>
            <year>2018</year>
            <month>May</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>595</fpage>
            <page-range>595-600</page-range>
            <pub-id pub-id-type="pmid">28688833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18126.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Francisco</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Nobre Menezes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carrilho Ferreira</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jorge</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Infante de Oliveira</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Canas da Silva</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Balloon aortic valvuloplasty in the transcatheter aortic valve implantation era: A single-center registry.</article-title>
            <source>Rev Port Cardiol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>251</fpage>
            <page-range>251-256</page-range>
            <pub-id pub-id-type="pmid">28318856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18126.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shivaraju</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thilo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sawlani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ott</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Schunkert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>von Scheidt</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kastrati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kasel</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Aortic Valve Predilatation with a Small Balloon, without Rapid Pacing, prior to Transfemoral Transcatheter Aortic Valve Replacement.</article-title>
            <source>Biomed Res Int</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>1080597</fpage>
            <pub-id pub-id-type="pmid">29854723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18126.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petit</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Qureshi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Glatz</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Kelleman</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>McCracken</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Ligon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Mozumdar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Whiteside</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>BH</given-names>
              </name>
            </person-group>
            <article-title>Technical factors are associated with complications and repeat intervention in neonates undergoing transcatheter right ventricular decompression for pulmonary atresia and intact ventricular septum: results from the congenital catheterisation research collaborative.</article-title>
            <source>Cardiol Young</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>28</volume>
            <issue>8</issue>
            <fpage>1042</fpage>
            <page-range>1042-1049</page-range>
            <pub-id pub-id-type="pmid">29909817</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
